Key result
Small-molecule PCSK9 inhibitors emerge as novel atherosclerosis candidates via virtual screening.
Answers are grounded in this paper and cite their sources.
Identifies potential therapeutics for atherosclerosis by inhibiting PCSK9, indicating new treatment options.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matthew N. Siciliano (2026) studied this question. Small molecule inhibitors of PCSK9 were discovered via virtual screening as potential therapeutics for atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: